HeraMED Limited (1I4) - Total Liabilities
Based on the latest financial reports, HeraMED Limited (1I4) has total liabilities worth €1.71 Million EUR (≈ $2.00 Million USD) as of December 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash efficiency ratio of HeraMED Limited to assess how effectively this company generates cash.
HeraMED Limited - Total Liabilities Trend (2018–2024)
This chart illustrates how HeraMED Limited's total liabilities have evolved over time, based on quarterly financial data. See HeraMED Limited book value and equity for net asset value and shareholders' equity analysis.
HeraMED Limited Competitors by Total Liabilities
The table below lists competitors of HeraMED Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Bflysoft Co. Ltd.
KQ:148780
|
Korea | ₩3.93 Billion |
|
Jade Marvel Group Bhd
KLSE:7043
|
Malaysia | RM28.48 Million |
|
Power Minerals Ltd
AU:PNN
|
Australia | AU$2.28 Million |
|
Plantynet Co. Ltd
KQ:075130
|
Korea | ₩13.74 Billion |
|
KD Chem Co. Ltd
KQ:221980
|
Korea | ₩30.42 Billion |
|
ORTOMA AB B
F:82Y
|
Germany | €18.63 Million |
|
Reka Industrial Oyj
HE:REKA
|
Finland | €18.80 Million |
|
Mundoro Capital Inc
V:MUN
|
Canada | CA$5.17 Million |
Liability Composition Analysis (2018–2024)
This chart breaks down HeraMED Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see HeraMED Limited stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.52 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.62 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.38 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how HeraMED Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for HeraMED Limited (2018–2024)
The table below shows the annual total liabilities of HeraMED Limited from 2018 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €1.71 Million ≈ $2.00 Million |
-36.90% |
| 2023-12-31 | €2.71 Million ≈ $3.17 Million |
+42.61% |
| 2022-12-31 | €1.90 Million ≈ $2.23 Million |
-59.45% |
| 2021-12-31 | €4.70 Million ≈ $5.49 Million |
+202.34% |
| 2020-12-31 | €1.55 Million ≈ $1.82 Million |
-10.53% |
| 2019-12-31 | €1.74 Million ≈ $2.03 Million |
+3.38% |
| 2018-12-31 | €1.68 Million ≈ $1.96 Million |
-- |
About HeraMED Limited
HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It also provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a remote fetal heart rate monitoring solution. The company has a collaboration agreement with Mayo Clinic for the … Read more